Methods: Dental implants were pre-coated biomimetically with a thin layer of calcium phosphate and then incubated in a supersaturated solution of calcium phosphate containing BMP-2 at a concentration of 10 mg/ml, under physiological conditions for 48 hours. Coated implants then underwent SEM, immunohistochemical evaluation, and FTIR and XRD analysis. The quantity of BMP-2 taken up by coatings was monitored colorimetrically.
Results: Dental implants were uniformly coated with a layer of 30-50 mm thick calcium phosphate coatings, in which BMP-2 was incorporated. SEM revealed coatings prepared in the absence of protein to be composed entirely of straight, plate-like units with sharp edges. Crystal geometry did not change as a function of BMP-2 within the solution. There was 3.65 mg of calcium phosphate coating material obtained from each implant at a BMP-2 concentration of 0.5mg/mg in the coating.
Conclusion: BMP-2 can be incorporated into biomimetic coatings of dental implants. We currently investigate the osseointegration potential of such implant in a miniature pig model.